Lidocaine Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine is a local anesthetic used to block nerve conduction in various clinical settings.

• Minor surgical or diagnostic procedures: provides rapid onset of numbness to facilitate painless intervention.
• Epidural anesthesia: enables regional block for labor or surgeries requiring lower‑body anesthesia.
• Intramuscular or intradermal infiltration for pain control: reduces localized pain during musculoskeletal or dermatologic interventions.

• Lidocaine reversibly binds to voltage‑gated sodium channels on neuronal membranes, stabilizing the inactive state of the channel. This blockade prevents the rapid influx of sodium ions required for depolarization, thereby inhibiting initiation and propagation of nerve impulses and producing a localized loss of sensation.

Lidocaine may cause a range of adverse reactions, most of which are dose‑dependent and related to its pharmacologic action.

Common Side Effects

• Burning or stinging at the injection site.
• Transient dizziness or light‑headedness.
• Mild nausea or headache.
• Temporary hypotension.
• Tingling or numbness beyond the intended area.

Serious or Rare Side Effects

• Methemoglobinemia leading to cyanosis.
• Cardiac arrhythmias or conduction disturbances.
• Central nervous system toxicity such as seizures.
• Severe allergic reactions including anaphylaxis.
• Respiratory depression or apnea.

When using Lidocaine Noridem, consider the following safety measures.

• Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics.
• Cardiovascular monitoring: observe for hypotension or arrhythmias during high‑dose administrations.
• Neurological status: watch for signs of CNS toxicity such as tinnitus, tremor, or seizures.
• Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited.
• Dosage limits: adhere to recommended maximum doses to avoid systemic toxicity.
• Store at ambient temperature: keep below 25°C, protect from moisture and light in the original container.

Lidocaine may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Class I antiarrhythmics (e.g., quinidine, procainamide): may enhance cardiotoxicity.
• Beta‑blockers (e.g., propranolol): increase risk of central nervous system depression.
• Strong CYP3A4 inhibitors (e.g., ketoconazole): raise plasma lidocaine concentrations.

Moderate Interactions (Monitor Closely)

• Class III antiarrhythmics (e.g., amiodarone): additive effects on cardiac conduction.
• Concurrent use of other local anesthetics (e.g., bupivacaine): risk of cumulative toxicity.
• Loop diuretics (e.g., furosemide): may alter protein binding and increase free lidocaine levels.